Sign in
SCHEDULE 13G/A

Statement of Beneficial Ownership

Vistagen Therapeutics, Inc. Filed Acc 0001831942-26-000051

Stakes reported in this filing

Reporting person Shares Of the class
Commodore Capital LP 1,690,014 3.7%
Commodore Capital Master LP 1,690,014 3.7%
Robert Egen Atkinson 1,690,014 3.7%
Michael Kramarz 1,690,014 3.7%

Members of a group can each report the same shares, so these rows overlap and don't add up.

Loading xslSCHEDULE_13G_X02/primary_doc.xml…